Jalalzadeh Mojgan, Cheng Mingyu
Internal Medicine/Transplant Nephrology, Baylor Scott & White Health, Temple, USA.
Pathology, Baylor Scott & White Health, Temple, USA.
Cureus. 2025 Jun 13;17(6):e85926. doi: 10.7759/cureus.85926. eCollection 2025 Jun.
We present a complex case of a 71-year-old man with end-stage renal disease secondary to autosomal dominant polycystic kidney disease who developed acute Banff 2A cellular rejection in association with BK virus nephropathy following a deceased donor kidney transplant. Despite the initial delayed graft function and subsequent wound complications, the patient stabilized with appropriate immunosuppression and antiviral prophylaxis. This case highlights the challenges of balancing immunosuppression for the management of graft rejection while minimizing viral activation, with an emphasis on evidence-based management of BK polyomavirus.
我们报告了一例复杂病例,一名71岁男性,因常染色体显性遗传性多囊肾病导致终末期肾病,在接受 deceased 供体肾移植后,发生了与BK病毒肾病相关的急性Banff 2A细胞性排斥反应。尽管最初出现移植肾功能延迟及随后的伤口并发症,但患者通过适当的免疫抑制和抗病毒预防措施病情稳定。该病例凸显了在管理移植排斥反应时平衡免疫抑制与尽量减少病毒激活之间的挑战,重点是基于证据的BK多瘤病毒管理。